Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Thalidomide-associated thrombocytopenia.

Michiel Duyvendak¹, Mark Naunton, Bert J Kingma

¹Department of Clinical Pharmacy, Tjongerschans Hospital, Heerenveen, Netherlands.

The Annals of Pharmacotherapy

|October 13, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pharmacists' contribution to improving vaccination uptake among children: A systematic review.

Research in social & administrative pharmacy : RSAP·2026

Same author

Methodological evaluation of the psychometric properties of medication-related quality indicators in residential aged care homes: a systematic review.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2026

Same author

Outcomes of pharmacist interventions as part of EAHOP - Enhancing allied health for older people in residential care.

Research in social & administrative pharmacy : RSAP·2025

Same author

Monte Carlo analysis of energy deposition and X-ray fluence in cylindrical anode systems.

Journal of applied clinical medical physics·2025

Same author

Response commentary: the effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists.

European journal of clinical pharmacology·2025

Same author

Optimization of vitamin K antagonist treatment: Near patient monitoring versus standard of care a parallel group clinical trial in older patients with atrial fibrillation.

European journal of clinical pharmacology·2025

Thalidomide, used for multiple myeloma (MM), can rarely cause thrombocytopenia (low platelet count). This case highlights the importance of monitoring platelet levels during thalidomide treatment due to potential adverse effects.

Area of Science:

Hematology
Oncology
Pharmacology

Background:

Multiple myeloma (MM) is a hematologic malignancy.
Thalidomide is an immunomodulatory drug used in MM treatment.
Standard MM therapies can lead to refractoriness and necessitate alternative treatments.

Observation:

A 70-year-old female MM patient developed severe adverse effects after initiating thalidomide monotherapy.
Symptoms included flu-like illness, rash, petechiae, neutropenia, and significant thrombocytopenia (58 x 10(9)/L).
Discontinuation of thalidomide led to rapid resolution of symptoms and normalization of platelet counts.

Findings:

Thalidomide was identified as the probable cause of thrombocytopenia in this patient.
Thrombocytopenia is a rare but serious hematologic adverse event associated with thalidomide.

Related Experiment Videos

This case aligns with a recent report of 5 other MM patients experiencing thalidomide-induced thrombocytopenia.

Implications:

Clinicians should be aware of the potential for thalidomide to cause thrombocytopenia.
Monitoring platelet counts is crucial for patients undergoing thalidomide therapy for MM.
Increased use of thalidomide in MM necessitates vigilance for its hematologic toxicities.